Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Psoriasis: HELP
Hernan Valdez
Based on 17 articles published since 2008
||||
Expertise Level
The expertise of Hernan Valdez ranks in the
  • Top 1.1%
  • ... of 37,573 published authors worldwide on Psoriasis
  • ... from 2008 through 2019
  • ... based on contributions to 17 articles on the topic.
Graphical view (beta)
Uncounted papers?
Aliases Valdez, Hernan   ·   Valdez, H
Work Locations
Details
Most likely:    Pfizer      
2018
  • Pfizer Early Clinical Development, Cambridge, MA, USA. · Pfizer Early Clinical Development, Groton, CT, USA. · Pfizer Global Innovative Pharmaceuticals, Groton, CT, USA. · Pfizer Global Innovative Pharmaceuticals, New York, NY, USA. · Pfizer Inflammation and Immunology Research Unit, Cambridge, MA, USA. · Pubmed 29748971
  • Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York, USA; Division of Dermatology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA. · Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York, USA; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. · Pfizer Early Clinical Development Precision Medicine, Cambridge, Massachusetts, USA. · The Center for Clinical and Translational Science, The Rockefeller University, New York, New York, USA. · Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York, USA. · Pfizer Global Research & Development, Groton, Connecticut, USA. · Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. · Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York, USA. Electronic address: · Pubmed 28927890
  • Oregon Health and Science University, Portland, Oregon. Electronic address: · University Hospitals Case Medical Center, Cleveland, Ohio. · Dermatology Treatment and Research Center, Dallas, Texas. · Pfizer Inc, Groton, Connecticut. · Pfizer Inc, Cambridge, Massachusetts. · Pfizer Inc, New York, NY. · Pfizer Inc, Collegeville, Pennsylvania. · Pubmed 29080806
2017
  • Pfizer Inc, Groton, Connecticut, USA. · Quantitative Solutions Inc., Menlo Park, California, USA. · Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona Medical School, Barcelona, Spain. · Pfizer Inc, New York, New York, USA. · Pfizer Inc, Collegeville, Pennsylvania, USA. · Pubmed 28480503
  • Ann Arbor Pharmacometrics Group (A2PG), Inc., Ann Arbor, Michigan, USA. · Probity Medical Research and K Papp Clinical Research Inc., Waterloo, Ontario, Canada. · Pfizer Inc., Groton, Connecticut, USA. · Pubmed 28317328
  • a Global Medicines Development, Global Innovative Pharma, Pfizer Inc , Groton , CT , USA. · b Global Medical Affairs, Global Innovative Pharma, Pfizer Inc. , New York , NY , USA. · c The Dermatology Centre , Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre , Manchester , UK. · d Psoriasis-Center at the Department of Dermatology , University Medical Center Schleswig-Holstein , Campus Kiel , Germany. · e Department of Dermatology, Feinberg School of Medicine , Northwestern University , Chicago , IL , USA. · Pubmed 27538247
  • Oregon Health and Science University, Portland, Oregon. Electronic address: · Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York. · Department of Quality Measures and Research, Clalit Health Services, Tel Aviv, Israel; Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel. · University of Texas Health Science Center, Houston, Texas. · Pfizer Inc, Groton, Connecticut. · Pfizer Inc, Collegeville, Pennsylvania. · Department of Dermatology and Allergy, Herlev and Gentofte Hospital, Hellerup, Denmark. · Pfizer Inc, New York, New York. · Pubmed 28711084
  • Pfizer Medicine Design, Groton, Connecticut, USA. · Pfizer Inflammation and Immunology Research Unit, Cambridge, Massachusetts, USA. · Pfizer Global Innovative Pharmaceuticals, New York, New York, USA. · Pfizer Precision Medicine Bioanalytical, Cambridge, Massachusetts, USA. · Research Statistics, Groton, Connecticut, USA. · Pfizer Medicine Design, Groton, Connecticut, USA. · Pubmed 28534291
2016
  • Wake Forest University School of Medicine, Winston-Salem, North Carolina. · Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany. · Skin Center for Dermatology and Probity Medical Research, Peterborough, Ontario, Canada. · Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Clinica Dermacross, Santiago, Chile. · Pfizer Inc, Collegeville, Pennsylvania. · Pfizer Inc, Groton, Connecticut. · Pfizer Inc, New York, New York. · Pfizer Inc, Groton, Connecticut. Electronic address: · Pubmed 27692733
  • Department of Dermatology, Faculty of Medicine, University of Chile and Probity Medical Research, Santiago, Chile. · Toulouse University and Larrey Hospital, Toulouse, France. · Pfizer Inc, Collegeville, PA, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, New York, NY, USA. · Pubmed 27271195
  • Rockefeller University, New York, NY. · Pfizer Inc, Cambridge, Mass. · Pfizer Inc, Groton, Conn. · Pfizer Inc, New York, NY. · Pfizer Inc, Groton, Conn. Electronic address: · Pubmed 27059729
  • Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. Electronic address: · University of Connecticut Health Center, Farmington, Connecticut; Probity Medical Research, Waterloo, Ontario, Canada. · Department of Cardiology, Herlev and Gentofte Hospital, Hellerup, Denmark. · Department of Cardiology, Copenhagen University Hospital Rigshospitalet, The Heart Centre, Copenhagen, Denmark. · Department of Cardiology, Herlev and Gentofte Hospital, Hellerup, Denmark; Department of Dermato-Allergology, Herlev and Gentofte Hospital, Hellerup, Denmark. · Department of Dermatology, Warren Alpert Medical School, Brown University, Providence, Rhode Island; Department of Epidemiology, School of Public Health, Brown University, Providence, Rhode Island. · Pfizer location in Collegeville, Collegeville, Pennsylvania. · Pfizer location in New York, New York, New York. · Pfizer location in Groton, Groton, Connecticut. · Pubmed 27498960
2015
  • Sorbonne Paris Cité Université Paris Diderot, Department of Dermatology, APHP Hôpital Saint-Louis, Paris, France. Electronic address: · Radboud University Nijmegen Medical Center, Nijmegen, Netherlands. · Federal Academic Teaching Hospital of Feldkirch, Feldkirch, Austria. · State Research Center of Dermatology and Venereology, Ministry of Health, Moscow, Russia. · University of Chile Clinical Hospital, Department of Dermatology, Santiago, Chile; Probity Medical Research, Waterloo, ON, Canada. · Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea. · Soloviev's Clinical Hospital for Urgent Medical Care, Yaroslav, Russia. · Department of Dermatology, University of Rome, Rome, Italy. · Pfizer Inc, Groton, CT, USA. · Pubmed 26051365
  • Department of Dermatology, Faculty of Medicine, University of Chile and Probity Medical Research, Santiago, Chile. · Clinical Research and Probity Medical Research, Waterloo, ON, Canada. · Department of Dermatology, Eastern Virginia Medical School and Virginia Clinical Research Inc., Norfolk, VA, USA. · Department of Dermatology, University of Texas Medical School, Houston, TX, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, Groton, CT, USA. · Quintiles, Cambridge, MA, USA. · Present address: Statistical Consulting & Solutions, LLC, Brookline, MA, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, New York, NY, USA. · Specialty Care Medicines Development Group, Pfizer Inc, 219 E 42nd Street, 7th Floor Room 50, NYO 219/07/01, New York, NY, 10017, USA. · Pubmed 25951857
  • Innovaderm Research, Montreal, QC, Canada. · Aarhus University Hospital, Aarhus, Denmark. · Department of Medicine/Dermatology, UCLA School of Medicine, Los Angeles, CA, U.S.A. · Salford Royal Hospital, Manchester Academic Health Science Centre, University of Manchester, Manchester, U.K. · Skin and Cancer Foundation Inc., The University of Melbourne, Carlton, Vic., Australia. · Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. · Pfizer Inc, Groton, CT, U.S.A. · Pfizer Inc, New York, NY, U.S.A. · Pfizer Inc, Collegeville, PA, U.S.A. · Pubmed 25418186
Possible:    University of Connecticut Farmington   Contact    
2013
  • Department of Dermatology, University of Connecticut School of Medicine, Farmington, CT, 06032, U.S.A; Probity Medical Research, Waterloo, ON, Canada. · Pubmed 23855761
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 17 total) written by Hernan Valdez about Psoriasis:

  • Association between serum interleukin-17A and clinical response to tofacitinib and etanercept in moderate to severe psoriasis. 2018
  • Reduction of Inflammatory and Cardiovascular Proteins in the Blood of Patients with Psoriasis: Differential Responses between Tofacitinib and Etanercept after 4 Weeks of Treatment. 2018
  • T-cell-mediated immune response to pneumococcal conjugate vaccine (PCV-13) and tetanus toxoid vaccine in patients with moderate-to-severe psoriasis during tofacitinib treatment. 2018
  • Quantitative Evaluations of Time-Course and Treatment Effects of Systemic Agents for Psoriasis: A Model-Based Meta-Analysis. 2017
  • Evaluating Dosage Optimality for Tofacitinib, an Oral Janus Kinase Inhibitor, in Plaque Psoriasis, and the Influence of Body Weight. 2017
  • Early clinical response to tofacitinib treatment as a predictor of subsequent efficacy: Results from two phase 3 studies of patients with moderate-to-severe plaque psoriasis. 2017
  • Herpes zoster in psoriasis patients treated with tofacitinib. 2017
  • Ultra-Sensitive Measurement of IL-17A and IL-17F in Psoriasis Patient Serum and Skin. 2017
  • Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis. 2016
  • Tofacitinib versus etanercept or placebo in patients with moderate to severe chronic plaque psoriasis: patient-reported outcomes from a Phase 3 study. 2016
Show List of Full Article Records
Google Searches

Learn more about Hernan Valdez using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Pfizer
University of Connecticut Farmington
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Pfizer
2018
  • Pfizer Early Clinical Development, Cambridge, MA, USA. · Pfizer Early Clinical Development, Groton, CT, USA. · Pfizer Global Innovative Pharmaceuticals, Groton, CT, USA. · Pfizer Global Innovative Pharmaceuticals, New York, NY, USA. · Pfizer Inflammation and Immunology Research Unit, Cambridge, MA, USA. · Pubmed 29748971
  • Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York, USA; Division of Dermatology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA. · Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York, USA; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. · Pfizer Early Clinical Development Precision Medicine, Cambridge, Massachusetts, USA. · The Center for Clinical and Translational Science, The Rockefeller University, New York, New York, USA. · Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York, USA. · Pfizer Global Research & Development, Groton, Connecticut, USA. · Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. · Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York, USA. Electronic address: · Pubmed 28927890
  • Oregon Health and Science University, Portland, Oregon. Electronic address: · University Hospitals Case Medical Center, Cleveland, Ohio. · Dermatology Treatment and Research Center, Dallas, Texas. · Pfizer Inc, Groton, Connecticut. · Pfizer Inc, Cambridge, Massachusetts. · Pfizer Inc, New York, NY. · Pfizer Inc, Collegeville, Pennsylvania. · Pubmed 29080806
2017
  • Pfizer Inc, Groton, Connecticut, USA. · Quantitative Solutions Inc., Menlo Park, California, USA. · Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona Medical School, Barcelona, Spain. · Pfizer Inc, New York, New York, USA. · Pfizer Inc, Collegeville, Pennsylvania, USA. · Pubmed 28480503
  • Ann Arbor Pharmacometrics Group (A2PG), Inc., Ann Arbor, Michigan, USA. · Probity Medical Research and K Papp Clinical Research Inc., Waterloo, Ontario, Canada. · Pfizer Inc., Groton, Connecticut, USA. · Pubmed 28317328
  • a Global Medicines Development, Global Innovative Pharma, Pfizer Inc , Groton , CT , USA. · b Global Medical Affairs, Global Innovative Pharma, Pfizer Inc. , New York , NY , USA. · c The Dermatology Centre , Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre , Manchester , UK. · d Psoriasis-Center at the Department of Dermatology , University Medical Center Schleswig-Holstein , Campus Kiel , Germany. · e Department of Dermatology, Feinberg School of Medicine , Northwestern University , Chicago , IL , USA. · Pubmed 27538247
  • Oregon Health and Science University, Portland, Oregon. Electronic address: · Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York. · Department of Quality Measures and Research, Clalit Health Services, Tel Aviv, Israel; Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel. · University of Texas Health Science Center, Houston, Texas. · Pfizer Inc, Groton, Connecticut. · Pfizer Inc, Collegeville, Pennsylvania. · Department of Dermatology and Allergy, Herlev and Gentofte Hospital, Hellerup, Denmark. · Pfizer Inc, New York, New York. · Pubmed 28711084
  • Pfizer Medicine Design, Groton, Connecticut, USA. · Pfizer Inflammation and Immunology Research Unit, Cambridge, Massachusetts, USA. · Pfizer Global Innovative Pharmaceuticals, New York, New York, USA. · Pfizer Precision Medicine Bioanalytical, Cambridge, Massachusetts, USA. · Research Statistics, Groton, Connecticut, USA. · Pfizer Medicine Design, Groton, Connecticut, USA. · Pubmed 28534291
2016
  • Wake Forest University School of Medicine, Winston-Salem, North Carolina. · Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany. · Skin Center for Dermatology and Probity Medical Research, Peterborough, Ontario, Canada. · Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Clinica Dermacross, Santiago, Chile. · Pfizer Inc, Collegeville, Pennsylvania. · Pfizer Inc, Groton, Connecticut. · Pfizer Inc, New York, New York. · Pfizer Inc, Groton, Connecticut. Electronic address: · Pubmed 27692733
  • Department of Dermatology, Faculty of Medicine, University of Chile and Probity Medical Research, Santiago, Chile. · Toulouse University and Larrey Hospital, Toulouse, France. · Pfizer Inc, Collegeville, PA, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, New York, NY, USA. · Pubmed 27271195
  • Rockefeller University, New York, NY. · Pfizer Inc, Cambridge, Mass. · Pfizer Inc, Groton, Conn. · Pfizer Inc, New York, NY. · Pfizer Inc, Groton, Conn. Electronic address: · Pubmed 27059729
  • Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. Electronic address: · University of Connecticut Health Center, Farmington, Connecticut; Probity Medical Research, Waterloo, Ontario, Canada. · Department of Cardiology, Herlev and Gentofte Hospital, Hellerup, Denmark. · Department of Cardiology, Copenhagen University Hospital Rigshospitalet, The Heart Centre, Copenhagen, Denmark. · Department of Cardiology, Herlev and Gentofte Hospital, Hellerup, Denmark; Department of Dermato-Allergology, Herlev and Gentofte Hospital, Hellerup, Denmark. · Department of Dermatology, Warren Alpert Medical School, Brown University, Providence, Rhode Island; Department of Epidemiology, School of Public Health, Brown University, Providence, Rhode Island. · Pfizer location in Collegeville, Collegeville, Pennsylvania. · Pfizer location in New York, New York, New York. · Pfizer location in Groton, Groton, Connecticut. · Pubmed 27498960
2015
  • Sorbonne Paris Cité Université Paris Diderot, Department of Dermatology, APHP Hôpital Saint-Louis, Paris, France. Electronic address: · Radboud University Nijmegen Medical Center, Nijmegen, Netherlands. · Federal Academic Teaching Hospital of Feldkirch, Feldkirch, Austria. · State Research Center of Dermatology and Venereology, Ministry of Health, Moscow, Russia. · University of Chile Clinical Hospital, Department of Dermatology, Santiago, Chile; Probity Medical Research, Waterloo, ON, Canada. · Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea. · Soloviev's Clinical Hospital for Urgent Medical Care, Yaroslav, Russia. · Department of Dermatology, University of Rome, Rome, Italy. · Pfizer Inc, Groton, CT, USA. · Pubmed 26051365
  • Department of Dermatology, Faculty of Medicine, University of Chile and Probity Medical Research, Santiago, Chile. · Clinical Research and Probity Medical Research, Waterloo, ON, Canada. · Department of Dermatology, Eastern Virginia Medical School and Virginia Clinical Research Inc., Norfolk, VA, USA. · Department of Dermatology, University of Texas Medical School, Houston, TX, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, Groton, CT, USA. · Quintiles, Cambridge, MA, USA. · Present address: Statistical Consulting & Solutions, LLC, Brookline, MA, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, New York, NY, USA. · Specialty Care Medicines Development Group, Pfizer Inc, 219 E 42nd Street, 7th Floor Room 50, NYO 219/07/01, New York, NY, 10017, USA. · Pubmed 25951857
  • Innovaderm Research, Montreal, QC, Canada. · Aarhus University Hospital, Aarhus, Denmark. · Department of Medicine/Dermatology, UCLA School of Medicine, Los Angeles, CA, U.S.A. · Salford Royal Hospital, Manchester Academic Health Science Centre, University of Manchester, Manchester, U.K. · Skin and Cancer Foundation Inc., The University of Melbourne, Carlton, Vic., Australia. · Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. · Pfizer Inc, Groton, CT, U.S.A. · Pfizer Inc, New York, NY, U.S.A. · Pfizer Inc, Collegeville, PA, U.S.A. · Pubmed 25418186
University of Connecticut Farmington
2013
  • Department of Dermatology, University of Connecticut School of Medicine, Farmington, CT, 06032, U.S.A; Probity Medical Research, Waterloo, ON, Canada. · Pubmed 23855761
Yearly article counts 035530100000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.